th international meeting integrated organizers€¦ · sunday, january 24, 2016 16:00 - 17:30...

www.cardio-congress.com

ORGANIZERS:KURT HUBER

(Austria)

HARALD DARIUS (Germany)

BERNARD GERSH (USA)

CHRIS GRANGER(USA)

OTMAR PACHINGER (Austria)

Innsbruck, AustriaAustria Trend Congress Hotel

January 23–26, 2016

MAIN TOPICS: Acute Coronary SyndromesAntiplatelet AgentsAnticoagulantsAtrial FibrillationBiomarkersCase PresentationsCongenital Heart Disease in AdultsCoronary Artery DiseaseCoronary and Non-Coronary DevicesDiabetes and HeartGuideline UpdatesHeart FailureInfections of the HeartInterventional CardiologyLipid Lowering StrategiesPreventionStructural Heart DiseaseTranslational Medicine (Poster-Sessions)

17th International Meeting

Integrated Management of Acute and Chronic Cardiovascular Disease

F I N A LP R O G R A M

1

PREFACE

This international meeting celebrates its 17th anniversary. As in the past, themeeting is organized by the Association for the Promotion of Research inArteriosclerosis, Thrombosis and Vascular Biology (ATVB), Vienna, Austria. Itis patronized by the European Platelet Academy (EPA), and by the WorkingGroup on Thrombosis of the ESC, respectively.

In 2016, more than 40 international and national experts will guarantee an interesting conference with important topics illustrating the mostcontemporary and topical clinical research data mainly in the field of acutecoronary syndromes, acute cardiac care, atrial fibrillation, heart failure andprevention (including new treatment strategies in lipid lowering, hypertension,and diabetes). A major focus will be on pharmacotherapy and devices as hasbeen the case in prior meetings.. Master lectures and interactive clinical casediscussions would extend our knowledge and enhance the practical relevanceof the program.

The number of attendees is limited to a maximum of 100 participants in orderto stimulate intense discussions with international experts on casepresentations and main topics – a rare situation in our world of mega-congresses. The invited experts will stay for the whole meeting and have animportant impact on these discussions.

The organizers will also invite the presenters of the best abstracts (a maximumof 18 abstracts will be accepted) to discuss their data with faculty membersin moderated poster presentations. The “best-of-translational medicine” and“best-of-clinical medicine” posters will be awarded with 3,000 € in total. Thisservice will mainly refer to the group of young “cardiologists of tomorrow”. Inaddition, presenters of posters will have free access to the whole meeting.

We would welcome your participation at this meeting.

With best regards

Kurt Huber(for the organizers)

DEADLINE FOR ABSTRACT SUBSTITUTIONJanuary 10, 2016

(send your abstracts, A4 format, directly to [email protected])

2

FINAL PROGRAM SCHEDULE

Saturday, January 23, 2016

Arrivals19:30 Welcome Cocktail20:00 Get-Together-Evening

Sunday, January 24, 2016

09:00 - 10:00 Symposium 1: Therapeutic Strategiesof ACS in Discussion IJoint Meeting with the WG onThrombosis of the ESCchairs: D, Gulba (DE), H. Schühlen (DE)

09:00 - 09:25 The Future Role of Cangrelor andVorapaxar(H. Darius, DE)

09:25 - 09:35 Case Presentation #1(H. Alber, AT)

09:35 - 10:00 Thrombus Aspiration(D. Dudek, PL)

10:00 - 11:00 Symposium 2: Overcoming Challenges in AtrialFibrillation(supported by Daiichi Sankyo Europe)moderator: F.W.A. Verheugt (NL)

10:00 - 10:40 A Deep Dive in Safety and Dose-reduction Data ofthe ENGAGE AF – TIMI 48 Trial (R. Giugliano, US)

10:40 - 11:00 Practical Use of NOACS: To Whom, When andHow?(C. Granger, US)

11:00 - 11:30 Break, Exhibition

3



11:30 - 12:30 Symposium 3: Guideline Update Ichairs: F. Van de Werf (BE), M. Grimm (AT)

11:30 - 11:55 Pericardial Disease(B. Maisch, DE)

11:55 - 12:05 Case Presentation #2(A Rab, AT)

12:05 - 12:30 Endocarditis(B. Maisch, DE)

12:30 - 13:30 Lunch Break, Exhibition, Moderated Posters (moderators: J. Wojta, AT, R. De Caterina, IT)

13:30 - 14:30 Symposium 4: New Advances in CardiovascularPharmacotherapy (supported by Boehringer Ingelheim)moderator: K. Huber (AT)

13:30 - 14:00 Idarucizumab (Praxbind®) – The First Antidote onthe Market(F.W.A. Verheugt, NL)

14:00 - 14:30 A New Antidiabetic Agent with Impact on CVEvents: Empaglifozin(T. Wascher, AT)

14:30 - 15:30 Symposium 5: Antithrombotic Therapy inChronic Renal Diseasechairs: J. Morais (PT), R. Welsh (CA)

14:30 - 14:50 Anticoagulants(R. De Caterina, IT)Antiplatelets(K. Schrör, DE)Antithrombotic Therapy for Patients with AFib onRenal Replacement Therapy(C. Granger, US)




16:00 - 17:30 Symposium 6: Antithrombotic therapy in ACS: An Unfolding Story(partially supported by The Medicines Company)chairs: D. Gulba (DE), F. Van de Werf (BE)

16:00 - 16:15 Case Presentation #3(S. de Waha, DE)

16:15 - 16:35 Bivalirudin – Pros and Cons(U. Zeymer, DE)

16:35 - 16:55 Clopidogrel, Prasugrel, or Ticagrelor: Crushed forAbsorption?(C. Granger, US)

16:55 - 17:10 Case Presentation #4(J. Sipötz, AT)

17:10 - 17:30 Duration of DAPT – Which Strategy for Whom?(H. Schühlen, DE)

17:30 - 18:10 Symposium 7: Controversies in InterventionalCardiologyChairs: I. Lang (AT), H. Thiele (DE)

17:30 - 17:50 TAVI for Moderate Risk PatientsPro – The Interventionalist’s View(M. Haude, DE)Contra – The Surgeon’s View(M. Grimm, AT)

17:50 - 18:10 STEMI: The Pharmaco-invasive Approach Is Here toStayPro(F. Van de Werf, BE)Contra(P. Clemmensen, DK)

18:10 - 18:35 Symposium 8: Master Lecture 1moderator: B. Gersh (US)Congential Heart Disease – Update 2016!(J. Deanfield (UK))

20:00 Faculty Dinner

4


Monday, January 25, 2016

09:00 - 11:05 Symposium 9: Guideline Updates IIchairs: W.-M. Franz (AT), P. Clemmensen (DK)

09:00 - 09:25 NSTEMI(S. Kristensen, DK)

09:25 - 09:40 Case Presentation #5(T. Brunner, AT)

09:40 - 10:00 Ventricular Arrhythmias and SCD(B. Merkely, HU)

10:00 - 11:00 Symposium 10: Controversial Issues in AcuteCardiovascular Carechairs: J. Mair (AT), U. Zeymer (DE)

10:00 - 10:10 Case Presentation #6(H. Schühlen, DE)

10:10 - 10:30 Cooling or Not Cooling(I. Lang (AT)

10:30 - 10:40 Case Presentation #7(R. Zimmermann, CDN)

10:40 - 11:00 The Use of IABP in Cardiogenic Shock(D. Zahger, IL)


11:30 - 12:40 Symposium 11: Evolving Stent Technology(supported partially by Biosensors)moderator: B. Gersh (US)

11:30 - 11:45 Case Presentation #8(R. Zweiker, AT)

11:45 - 12:05 The LEADERS FREE Trial – Implications for RoutineClinical Practice? (K. Huber, AT)

12:05 - 12:20 Case Presentation #9(S. Harb, AT)

12:20 - 12:40 Bioabsorbable Scaffolds – An Update(D. Dudek, PL)

12:30 - 13:30 Lunch Break, Exhibition, Moderated Posters(moderators: I. Lang, AT, M. Möckel, DE)

5



13:30 - 14:30 Symposium 12: New Strategies in Heart Failuremoderator: O. Pachinger (AT)

11:30 - 12:00 Seralaxin and LCZ 696(K. Huber, AT)

12:00 - 12:30 Evolving and Future Approaches to theManagement of Heart Failure(B. Gersh US)

14:30 - 15:30 Symposium 13: Biomarkers in Cardiology – New OptionsJoint Meeting with the Acute CardiovascularCare Association of the ESC(partially supported by ThermoFisher/B.R.A.H.M.S.)chairs: H. Schühlen (DE), P. Goldstein (FR)

14:30 - 14:50 AMI Diagnosis in the ED: Troponin LoD, Grey Zone,High Levels and the Role of Copeptin(M. Möckel, DE)

14:50 - 15:10 BNP or Nt-proBNP – A View Point(J. Mair, AT))

15:10 - 15:30 High-sensitive Troponin – Is a 1 Hour StrategyFeasable?(C. Müller, CH)


16:00 - 17:15 Symposium 14: Arrhythmiaschairs: D. Zahger (IL), B. Merkely (HU)

16:00 - 16:25 Silent AFIB, Anticoagulation and the Role ofScreening(M. Borggrefe, DE)

16:25 - 16:40 Case Presentation #10(R. Zimmermann, CD)

16:40 - 17:00 The Leadless Pacemaker – A Critical Evaluation(M. Borggrefe, DE)

17:00 - 17:15 Case Presentation #11(E. Wessely, AT)


6

7



17:45 - 18:35 Master Lectures 2&3moderator: H. Darius (DE)

17:45 - 18:10 Reperfusion Injury and Cardioprotection – A Longand Bumpy Road(B. Gersh, US)

18:10 - 18:35 Impact of New Imaging Strategies on InterventionalCardiology(J. Hill, UK)

20:00 Networking Evening

8


Tuesday, January 26, 2016

09:00 - 11:00 Symposium 15: Pharmacological Prevention ofCADchairs: J. Deanfield (UK), K. Schrör (DE)

09:00 - 09:15 Case Presentation #12(G. Delle-Karth, AT)

09:15 - 09:40 What Is the Lowest Target for LDL Reduction?(H. Drexel, AT)

09:40 - 09:55 Case Presentation #13(S. De Waha, DE)

09:55 - 10:20 How to Define Statin Intolerance(C. Granger, US)

10:20 - 10:35 Case Presentation #14(U. Zeymer, DE)

10:35 - 11:00 How to Handle Antidiabetic Agents in CAD Patients(T. Wascher, AT)


11:30 - 12:30 Symposium 14: Alirocumab: A Boost in LipidManagement?(supported by SANOFI)chairs: H. Drexel (AT), G. Delle-Karth (AT)

11:30 - 11:50 PCSK9 Inhibition: From Proof of Concept IntoClinical Practice(H. Drexel AT)

11:50 - 12:10 Cardiovascular Risk Reduction with PCSK9Inhibition: Insight and Long-term CardiovascularOutcomes(R. Zweiker, AT)

12:10 - 12:30 Accumulating Clinical Data on Alirocumab: What Are the Key Lessons?(T. Wascher, AT)

12:30 - 13:30 Lunch Break, Exhibition, Moderated Posters III(moderators: J. Wojta, AT, S. Kristensen, DK)

9


Tuesday, January 26, 2016

13:30 - 14:10 Symposium 15: Therapeutic Strategies of ACS inDiscussion IIchairs: P. Goldstein (FR), M. Haude (DE)

13:30 - 13:50 Pre-hospital Antithrombotic Therapy(S. Kristensen, DK)

13:50 - 14:10 The Role of Angiography With Out of HospitalCardiac Arrest With/Without ST Elevation(H. Thiele, DE)

14:10 - 15:40 Symposium 16: Issues in Acute and ChronicRevascularizationchairs: D. Dudek (PL), W.-M. Franz (AT)

14:10 - 14:30 NSTEMI Systems of Care(R. Welsh, CD)

14:30 - 14:50 FFR – Invasive & Non-invasive: A New GoldStandard(J. Hill, UK)

14:50 - 15:10 Management of Multivessel Disease in Stable CAD (O. Pachinger, AT)

15:10 - 15:30 ACS – the Mirror of Real Life: Realty of Delays(P. Goldstein, FR)

15:30 - 15:45 Coffee Break

15:45 - 16:35 Symposium 17: Master Lectures 4&5chairs: C. Müller (CH), O. Pachinger (AT)

15:45 - 16:10 Prevention(J. Deanfield, UK)

16:10 - 16:35 Antithrombotics in the Elderly(J. Morais, PO)

16:35 FarewellK. Huber (AT)

Departures

10

GENERAL INFORMATION

Meeting OrganizationAssociation for the Promotion of Research in Arteriosclerosis,Thrombosis and Vascular Biology (ATVB) Mariahilferstrasse 49, A-1060 Vienna, Austria

Responsible for the Scientific ProgramKurt Huber, MD, FESC, FACC Director, 3rd Department of Medicine Cardiology & Intensive Care Medicine, Wilhelminenhospital Montleartstrasse 37, A-1160 Vienna, Austria Phone: (+43/1) 49 150-2301, Fax: (+43/1) 49 150-2309 E-mail: [email protected] or [email protected]

Congress Secretariat Congress and Study Concept GesmbH Widerhoferplatz 4/3/19, A-1090 Vienna, Austria Contact: Ms. Mag. Franziska Beckmann Phone/Fax: (+43/699) 115 16917 E-mail: [email protected]

Medical Exhibition and Advertising Medizinische Ausstellungs- und Werbegesellschaft Freyung 6, A-1014 Vienna, Austria Contact: Ms. Sonja Chmella Phone: (+43/1) 536 63-32, Fax: (+43/1) 535 60 16 E-mail: [email protected], www.maw.co.at

Venue Austria Trend Hotel, InnsbruckRennweg 12a, A-6020 Innsbruck, AustriaPhone: (+43/512) 2115-0, Fax: (+43/512) 2115-500E-mail: [email protected]

Congress Fee€ 600.–/300.– (reduced fee for physicians in education)2-day attendance: € 400.–/200.–1-day attendance: € 200.–/100.–

Online Registrationhttps://registration.maw.co.at/coronary16


GENERAL INFORMATION

Information for Poster PresentersYou will get notion of acceptance of your abstract latest until January20, 2016. There will be free access to the whole meeting for posterpresenters. Posters (130x90 cm) should be mounted on the respectiveindicted day (Sunday, Monday, or Tuesday) from 9:00 AM to 7:00 PM.Poster presentation (3 min) and discussion (3 min) will take part duringthe indicated poster moderation sessions. The best basic and clinical research posters will be awarded.


11

12

SPONSORS (per November, 2015)

AstraZeneca

International FacultyMartin BORGGREFE (Germany)Peter CLEMMENSEN (Denmark)Raffaele DE CATERINA (Italy)Harald DARIUS (Germany)John DEANFIELD (United Kingdom)Georg DELLE-KARTH (Wien)Suzanne DE WAHA (Germany)Heinz DREXEL (Austria)Dariusz DUDEK (Poland)Wolfgang-Michael FRANZ (Austria)Bernard GERSH (USA)Robert GIUGLIANO (USA)Patrick GOLDSTEIN (France)Chris GRANGER (USA)Michael GRIMM (Austria)Dietrich GULBA (Germany)Michael HAUDE (Germany)Jonathan HILL (United Kingdom)Kurt HUBER (Austria)

Steen D. KRISTENSEN (Denmark)Irene LANG (Austria)

Johannes MAIR (Austria)Bernhard MAISCH (Germany)

Bela MERKELY (Hungary)Martin MÖCKEL (Germany)

Joao MORAIS (Portugal)Christian MÜLLER (Switzerland)

Otmar PACHINGER (Austria)Karsten SCHROER (Düsseldorf)

Helmut SCHÜHLEN (Germany)Holger THIELE (Germany)

Frans VAN DE WERF (Belgium)Freek VERHEUGT (The Netherlands)

Thomas WASCHER (Austria)Rob WELSH (Canada)

Johann WOJTA (Austria)Doron ZAHGER (Israel)

Uwe ZEYMER (Germany)Rod ZIMMERMANN (Canada)

Robert ZWEIKER (Graz)Austrian Faculty - Case Presenters

Hannes ALBER (Innsbruck)Thomas BRUNNER (Wiener Neustadt)

Stefan HARB (Graz)Anna RAB (Klagenfurt)

Johann SIPPÖTZ (Wien)Wolfgang TKALEC (Linz)

Emil WESSELY (Wien)

www.cardio-congress.comPrinted in Austria by: ROBIDRUCKA-1200 Vienna – www.robidruck.co.at

th international meeting integrated organizers€¦ · sunday, january 24, 2016 16:00 - 17:30...

Documents